Brief: Docmorris Confirms Targets For 2024
Oct 15 (Reuters) - DocMorris AG DOCM.S :
* DOCMORRIS ACCELERATES RX GROWTH
* RX REVENUE GROWTH OF 12.2 PER CENT IN Q3
* OTC GROWTH OF 1.9 PER CENT
* PABLO ROS GOMEZ BECOMES NEW CTO
* DOCMORRIS CONFIRMS TARGETS FOR 2024 COMMUNICATED IN AUGUST
* DOCMORRIS WILL CLOSE ITS ZUR ROSE PHARMA GMBH SERVICE
LOCATION
ON 31 DECEMBER 2024
Source text for Eikon: ID:nEQ25vJNya
Further company coverage: DOCM.S
(Gdansk Newsroom)
(((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on DocMorris AG
See all newsEurope Research Roundup: Barclays, Societe Generale, UBS Group
Europe Research Roundup: Barclays, Societe Generale, UBS Group
Brief: Shareholder CEPD Says It Rejects DocMorris' Mischaracterisation And Emphasizes Case For Real Governance Reform
DocMorris rises on 'strong' Q1 results
Brief: Docmorris Says Qtrly Revenue Rose By 11.7 Per Cent To CHF 303.8 Million